X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

TNYA

Closed

Tenaya Therapeutics Inc

4.54
+0.18 (+4.13%)
Last Update: 24 May 2024 23:07:00
Yesterday: 4.36
Day's Range: 4.23 - 4.6
Send
When Written:
 
3.02
Tenaya Therapeutics Inc is a biotechnology company that is focused on developing treatments for heart disease. The company was founded in 2016 and is based in South San Francisco, California. Tenaya's research is centered around the use of regenerative medicine and gene therapy to treat heart failure and other cardiovascular diseases. The company's lead drug candidate, TTX-080, is a gene therapy designed to restore heart function by increasing the production of a protein called SERCA2a. Tenaya has raised over $130 million in funding from investors such as The Column Group, Casdin Capital, and GV (formerly Google Ventures).

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:3.235.20.185
X